Page last updated: 2024-10-28

hydroxychloroquine and Cytomegalovirus Retinitis

hydroxychloroquine has been researched along with Cytomegalovirus Retinitis in 1 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Cytomegalovirus Retinitis: Infection of the retina by cytomegalovirus characterized by retinal necrosis, hemorrhage, vessel sheathing, and retinal edema. Cytomegalovirus retinitis is a major opportunistic infection in AIDS patients and can cause blindness.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shahnaz, S1
Choksi, MT1
Tan, IJ1

Other Studies

1 other study available for hydroxychloroquine and Cytomegalovirus Retinitis

ArticleYear
Bilateral cytomegalovirus retinitis in a patient with systemic lupus erythematosus and end-stage renal disease.
    Mayo Clinic proceedings, 2003, Volume: 78, Issue:11

    Topics: Adult; Antirheumatic Agents; Azathioprine; Cytomegalovirus Retinitis; Female; HIV Seronegativity; Hu

2003